CP
Therapeutic Areas
iOnctura Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Roginolisib (IOA-244) | Oncology (unspecified) | Phase 2 |
| Cambritaxestat (IOA-289) | Oncology (unspecified) | Phase 2 |
| IOA-359 | Oncology (unspecified) | Phase 1 |
| Drug | Indication | Phase |
|---|---|---|
| Roginolisib (IOA-244) | Oncology (unspecified) | Phase 2 |
| Cambritaxestat (IOA-289) | Oncology (unspecified) | Phase 2 |
| IOA-359 | Oncology (unspecified) | Phase 1 |